| 2025 | Perceived usefulness, benefits, and needs of patient-generated health data among older adults after lung cancer surgery
| GERIATRIC NURSING |
| 2025 | Stereotactic Ablative Radiotherapy versus Surgery in Patients with Pulmonary Metastases from Colorectal Cancer
| CANCER RESEARCH AND TREATMENT |
| 2025 | Deciphering the intratumoral histologic heterogeneity of lung adenocarcinoma using radiomics | EUROPEAN RADIOLOGY |
| 2025 | Outcomes of Donor/Recipient Size-mismatched Lung Transplantation | TRANSPLANTATION PROCEEDINGS |
| 2025 | Comparison of Stereotactic Body Radiotherapy and Surgery for Stage I Lung Cancer: A Multidisciplinary Cohort Study Utilizing Propensity Score Overlap Weighting and AI-Based CT Imaging Analysis
| CANCERS |
| 2025 | Neoadjuvant and Adjuvant Osimertinib in Stage IA to IIIA, EGFR-Mutant NSCLC (NORA)
| JOURNAL OF THORACIC ONCOLOGY |
| 2025 | Patterns and preoperative risk factors of occult lymph node metastasis in clinical stage I lung cancer | LUNG CANCER |
| 2025 | Stereotactic body radiotherapy for early‑stage non‑small cell lung cancer: Comprehensive analysis of outcomes and recurrence from a single‑center experience
| ONCOLOGY LETTERS |
| 2024 | ASO Visual Abstract: Completely Resectable (cT1-2) Esophageal Squamous Cell Carcinoma with Minimal Lymph Node Involvement (cN1): Is Neoadjuvant Chemoradiation Therapy the Only Viable Treatment Option? | ANNALS OF SURGICAL ONCOLOGY |
| 2024 | Completely Resectable (cT1-2) Esophageal Squamous Cell Carcinoma with Minimal Lymph Node Involvement (cN1): Is Neoadjuvant Chemoradiation Therapy the Only Viable Treatment Option? | ANNALS OF SURGICAL ONCOLOGY |
| 2024 | Stereotypic T cell receptor clonotypes in the thymus and peripheral blood of Myasthenia gravis patients
| HELIYON |
| 2024 | Germinal centers are associated with postthymectomy myasthenia gravis in patients with thymoma | EUROPEAN JOURNAL OF NEUROLOGY |
| 2023 | ASO Visual Abstract: Immediate Postoperative High Syndecan-1 is Associated with Short-Term Morbidity and Mortality After Robot-Assisted Esophagectomy-A Prospective Observational Study | ANNALS OF SURGICAL ONCOLOGY |
| 2023 | Importance of Local Ablative Therapies for Lung Metastases in Patients With Colorectal Cancer | ANNALS OF SURGERY |
| 2023 | Immediate Postoperative High Syndecan-1 is Associated with Short-Term Morbidity and Mortality After Robot-Assisted Esophagectomy: A Prospective Observational Study | ANNALS OF SURGICAL ONCOLOGY |
| 2023 | Clinical Outcomes of Thymic Carcinoma: The Role of Radiotherapy Combined with Multimodal Treatments
| CANCERS |
| 2023 | Risk factors of pneumothorax and pneumomediastinum in COVID-19: a matched case-control study
| BMC INFECTIOUS DISEASES |
| 2023 | The Role of Adjuvant Therapy Following Surgical Resection of Small Cell Lung Cancer: A Multi-Center Study
| CANCER RESEARCH AND TREATMENT |
| 2023 | Proposal of a revised International Association for the Study of Lung Cancer grading system in pulmonary non-mucinous adenocarcinoma: The importance of the lepidic proportion | LUNG CANCER |
| 2022 | Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea
| THORACIC CANCER |
| 2022 | Skeletonizing En Bloc Esophagectomy Revisited: Oncologic Outcome in Association with the Presence of Thoracic Duct Lymph Nodes | ANNALS OF SURGICAL ONCOLOGY |
| 2022 | Postoperative bronchopleural fistula repair: Surgical outcomes and adverse factors for its success
| THORACIC CANCER |
| 2021 | Effects of mediastinal lymph node dissection in colorectal cancer-related pulmonary metastasectomy
| THORACIC CANCER |
| 2021 | Positive nodal status is still a risk factor for long-term survivors of non-small cell lung cancer 5 years after complete resection
| JOURNAL OF THORACIC DISEASE |
| 2021 | Robot-Assisted Thoracoscopic Esophagectomy with Total Mediastinal Lymphadenectomy: A Guide to a Systematic Approach Using the Concept of Fascial Plane Dissection
| Journal of Chest Surgery |
| 2021 | Genetic Analysis and Operative Outcomes in Patients with Oncogene-Driven Advanced NSCLC Treated with Cytoreductive Surgery as a Component of Local Consolidative Therapy
| CANCERS |
